StocksMedium•10 November 2026•
1 min read
Exagen Inc. Reports $0.25 Q3 Loss Per Share, Missing Analyst Estimates
Key Facts
1Exagen Inc. reported a quarterly loss of $0.25 per share, wider than the Zacks Consensus Estimate of a $0.19 loss.
2The current quarter's results compare to a loss of $0.19 per share reported in the same period a year ago.
Exagen Inc. reported a quarterly loss of $0.25 per share for the third quarter of 2026. Zacks reported that this loss was wider than the consensus estimate of $0.19 per share, and also compared unfavorably to the $0.19 per share loss recorded during the same period last year.
XGN closed at $7.1 on November 9, 2026, with the stock trading between a low of $5.9 and a high of $7.19 during that session. These financial results come as the company exceeded total revenue estimates for the current quarter despite the deepening net loss.